IRIS
OTTANA', Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.898
EU - Europa 3.329
AS - Asia 575
SA - Sud America 7
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.816
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.882
IE - Irlanda 1.048
SE - Svezia 941
CN - Cina 501
UA - Ucraina 380
DE - Germania 272
IT - Italia 223
FI - Finlandia 183
GB - Regno Unito 103
PL - Polonia 50
FR - Francia 34
IN - India 31
RU - Federazione Russa 26
AT - Austria 24
IR - Iran 21
BE - Belgio 17
CA - Canada 15
NL - Olanda 8
CH - Svizzera 6
JP - Giappone 6
KR - Corea 6
AU - Australia 5
BR - Brasile 5
GR - Grecia 5
VN - Vietnam 5
NO - Norvegia 3
CL - Cile 2
EU - Europa 2
RS - Serbia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
HR - Croazia 1
LV - Lettonia 1
MX - Messico 1
PK - Pakistan 1
PT - Portogallo 1
Totale 7.816
Salva come PNG Salva come JPEG
Città #
Dublin 1.047
Jacksonville 782
Chandler 712
Nyköping 594
Dearborn 434
Beijing 202
Princeton 181
Medford 176
Cambridge 171
Ashburn 118
Des Moines 97
Ann Arbor 94
Boardman 91
San Mateo 61
Messina 58
Jinan 48
Warsaw 48
Wilmington 46
Woodbridge 33
New York 27
Lancaster 25
Shenyang 24
Vienna 24
Haikou 23
Nanjing 23
Brussels 17
Hebei 16
Ardabil 15
Tianjin 15
Seattle 14
Fuzhou 12
Ningbo 12
Taiyuan 12
Taizhou 12
Guangzhou 11
Hefei 11
Houston 11
Francofonte 10
Nanchang 10
Pune 10
Washington 10
Windsor 10
Bremen 9
Augusta 8
Jiaxing 8
Zhengzhou 8
Los Angeles 7
Milan 7
Norwalk 7
Auburn Hills 6
Changsha 6
Hangzhou 6
Helsinki 6
Kunming 6
Monmouth Junction 6
Redwood City 6
Saint Petersburg 6
Turku 6
Reggio Calabria 5
Amsterdam 4
Bologna 4
Dong Ket 4
Geneva 4
Hyderabad 4
Riva 4
Torino 4
Turin 4
Aci Catena 3
Berkeley 3
Chengdu 3
Clearwater 3
Den Haag 3
Falls Church 3
Fontaniva 3
Lanzhou 3
Moscow 3
Mountain View 3
Nocera Terinese 3
Pietra Ligure 3
Shanghai 3
Ajax 2
Büdelsdorf 2
Casirate D'adda 2
Catania 2
Ceres 2
Chicago 2
Cupertino 2
Giussano 2
Hanover 2
Houssen 2
Joensuu 2
Kemerovo 2
London 2
Mumbai 2
Perugia 2
Riomaggiore 2
Rome 2
Salerno 2
Scanzano Jonico 2
Serra 2
Totale 5.571
Salva come PNG Salva come JPEG
Nome #
Synthesis of tertiary alkyl-substituted acetylenes by electrophilic addition to silylacetylenes 106
Evaluation of the anti-inflammatory/chondroprotective activity of aldose reductase inhibitors in human chondrocyte cultures 94
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 78
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 76
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 76
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 75
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 73
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 72
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 72
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions 72
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 69
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 68
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 67
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 67
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 67
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 65
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 64
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 63
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatase inhibitors. 63
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 63
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 63
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 63
3,3'-bi(1,3-thiazolidin-4-one) system. VIII. 3,3'-(1,2-ethanediyl) derivatives and corresponding 1,1'-disulfones: Synthesis, stereochemistry and antiinflammatory activity 63
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 62
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 62
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 61
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 61
3-ARYL-5-ARYLIDENE-2-THIOXO-4-IMIDAZOLIDINONE DERIVATIVES AS NEW PTP1B ALLOSTERIC INHIBITORS 60
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 59
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 59
Comparative activity of 5-arylidene-2-thioxo-4-thiazolidinone derivatives in chondrocytes and cartilage: MMP-3 inhibition and determination of GAGs release. 59
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications 59
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 58
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 58
(5-Arylidene-2,4-dioxothiazolidin-3-yl)acetic acids as aldose reductase inhibitors 58
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 57
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 57
2-(4-pyridyl)-Delta(2)-1,3,4-oxadiazolines from isonicotinoylhydrazones and diazomethane as potential antimycobacterial and anti-HIV agents .5. 57
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 57
AMINOPYRAZINYL DERIVATIVES - SYNTHESIS AND EVALUATION OF ANTIINFLAMMATORY AND RELATED ACTIVITIES 57
2,4-thiazolidinedione and 2-thioxo-4-thiazolidinone derivatives as aldose reductase inhibitors in the search for drugs to prevent long-term diabetes complications. 57
VALUTAZIONE DI COX-2 SELETTIVITÀ SU 3,3'-(1,2-ETANEDIIL)-BIS[2-(3,4-DIMETOSSIFENIL)-4-TIAZOLIDINONI] CHIRALI 56
Structure of Aldehyde Reductase in Ternary Complex with a 5-Arylidene-2,4-thiazolidinedione Aldose Reductase Inhibitor 56
Non-carboxylic acid 5-arylidene-2,4-thiazolidinedione derivatives as aldose reductase inhibitors 56
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 55
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 55
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 55
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 55
HALOGENATED ISONIAZID DERIVATIVES AS POSSIBLE ANTIMYCOBACTERIAL AND ANTI-HIV AGENTS .3. 55
New 4-[(5-arylidene-2-arylimino-4-oxo-3-thiazolidinyl)methyl]benzoic acids active as protein tyrosine phosphatase inhibitors endowed with insulinomimetic effect on mouse C2C12 skeletal muscle cells 55
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 54
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 54
HALOGENATED ISONIAZID DERIVATIVES .4. 1-METHYLIDENEAMINO-2- TRIFLUOROMETHYLAZIRIDINES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 54
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 54
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 54
Progettazione e sintesi di 5-ariliden-4-tiazolidinoni e analoghi come inibitori di protein tirosina fosfatasi 54
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 54
Valutazione dell'attività antidegenerativa di 2-tiosso-4-tiazolidinoni su colture di condrociti umani 54
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 53
HALOGENATED ISONIAZID DERIVATIVES .2. UNUSUAL SYNTHESIS OF DELTA(2)-1,3,4-OXADIAZOLINE DERIVATIVES FROM ISONICOTINOYLHYDRAZONES AND DIAZOMETHANE 53
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 52
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 52
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 52
Utilization of zeolites in agriculture. Part II: Influence in spinach growing. 52
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 52
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 52
Sintesi di 5-ariliden-2-fenilimino-4-tiazolidinoni attivi come inibitori di protein tirosina fosfatasi. 52
Nuovi derivati 5-feniletossibenziliden-4-tiazolidinonici attivi come inibitori della protein tirosina fosfatasi 1B. 52
Sintesi di idrocarburi da metanolo su zeoliti commerciali. Relazione fra attività catalitica e acidità 52
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 51
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell’aldoso reduttasi. 51
2,4-Thiazolidinediones as in vitro ALR2 inhibitors for the treatment of diabetic complications 51
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 50
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 50
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agents 50
null 50
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 49
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 49
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors. 49
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 48
Azione insulinomimetica di acidi [4-(5-ariliden-2-arilimino-4-ossotiazolidin-3-il)metil]benzoici attivi come inibitori delle fosfatasi PTP1B e LMW-PTP 48
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 48
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 47
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 47
Protein-tyrosine phosphatase-1B mediates sleep fragmentation-induced insulin resistance and visceral adipose tissue inflammation in mice 47
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 46
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 46
Sintesi di nuovi inibitori dell’aldoso reduttasi come agenti per il trattamento delle complicazioni diabetiche. 46
Low Molecular Weight Phosphotyrosine Protein Phosphatases as Emerging Targetsfor the Design of Novel Therapeutic Agents 46
Design and synthesis of dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B 46
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 45
Nuovi 5-ariliden-2,4-tiazolidindioni non carbossilici inibitori dell'aldoso reduttasi 45
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 45
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 45
Synthesis of mono- and di-cyanoborane adducts from isonicotinoylhydrazones and sodium cyanoborohydride 44
Design, synthesis and evaluation of new aldose reductase inhibitors as agents for the treatment of diabetes complications. 44
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 44
Identification of novel 5 arylidene-3-phenyl-2 thioxoimidazolidin-4-ones as inhibitors of the chymotrypsin-like activities of the constitutive and immuno-proteasomes 44
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 44
Chondroprotective activity of 5-arylidene-4-thiazolidinone derivatives as new inhibitors of matrix metalloproteinase-13 43
Totale 5.659
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.666
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201927 0 0 0 0 0 0 0 0 0 0 7 20
2019/20201.561 219 96 1 89 116 298 291 149 27 83 182 10
2020/2021987 140 15 178 40 77 128 18 94 29 117 110 41
2021/20221.073 6 136 34 42 61 5 72 43 13 106 168 387
2022/20232.957 234 285 143 263 198 312 68 129 1.219 13 64 29
2023/2024449 37 94 75 41 57 96 7 27 0 15 0 0
Totale 7.895